Wall Street’s record-setting rally is due for a reality check, according to the latest report from Stifel’s Barry Bannister ...

People with certain serious health conditions now on the “Compassionate Allowances” list may receive benefits more quickly.

Shares of wind turbine maker Orsted lost as much as 29% as the company announced it’ll sell 60 billion Danish kroner ($9.3 ...

Investors will be looking closely at consumer-price index data due Tuesday and producer-price index data due Thursday. The ...

AI software company expects to report disappointing results, and some on Wall Street think it could take more time to right ...

Inflows into fixed-income bond ETFs and mutual funds jumped to more than $22.5 billion over a five-day period that ended last ...

The blue-chip Dow was trading lower Monday, but off the session's low, as President Donald Trump talked about an upcoming ...

Marks & Spencer Group PLC MKS shares advanced 2.95% to £3.42 Monday, on what proved to be an all-around positive trading ...

Seven in 10 investors say the economy is heading for stagflation, though their investment choices are not entirely consistent ...

Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...

Shares of 180 Life Sciences climbed after the company sold $156 million in convertible notes in order to load up its ether reserves. The stock was up 11% at $3.32 in afternoon trading. Shares have now ...

Intel’s turnaround is at risk given political criticism of CEO Lip-Bu Tan. Can he and Trump work together to resurrect U.S.